Carindacillin
From Wikipedia, the free encyclopedia
 |
|
|
Carindacillin
|
|
| Systematic (IUPAC) name | |
| (2S,5R,6R)-6-([3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C26H26N2O6S |
| Mol. mass | 494.55 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
℞ Prescription only |
| Routes | Oral |
Carindacillin (INN) is a penicillin antibiotic. It is a prodrug of carbenicillin.[1]
[edit] References
- ^ English AR, Retsema JA, Ray VA, Lynch JE (March 1972). "Carbenicillin indanyl sodium, an orally active derivative of carbenicillin". Antimicrob. Agents Chemother. 1 (3): 185–91. PMID 4558137. PMC:444190.
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
